These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36310922)

  • 21. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies.
    Moore KBE; Hung TJ; Fortin JS
    Drug Discov Today; 2023 Mar; 28(3):103487. PubMed ID: 36634842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    Barba L; Abu Rumeileh S; Bellomo G; Paolini Paoletti F; Halbgebauer S; Oeckl P; Steinacker P; Massa F; Gaetani L; Parnetti L; Otto M
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):83-86. PubMed ID: 35944974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation.
    Shin WS; Di J; Murray KA; Sun C; Li B; Bitan G; Jiang L
    Front Mol Neurosci; 2019; 12():268. PubMed ID: 31787880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
    Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
    Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation and synergistic fibrillization of tau and alpha-synuclein.
    Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
    Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.
    Permanne B; Sand A; Ousson S; Nény M; Hantson J; Schubert R; Wiessner C; Quattropani A; Beher D
    ACS Chem Neurosci; 2022 Apr; 13(8):1296-1314. PubMed ID: 35357812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complexity of tau in Alzheimer's disease.
    Naseri NN; Wang H; Guo J; Sharma M; Luo W
    Neurosci Lett; 2019 Jul; 705():183-194. PubMed ID: 31028844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Levels of
    Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C
    Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
    Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
    Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron.
    Han J; Fan Y; Wu P; Huang Z; Li X; Zhao L; Ji Y; Zhu M
    Front Aging Neurosci; 2021; 13():743754. PubMed ID: 34707492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer's Disease.
    Monge-García V; García-Ayllón MS; Sáez-Valero J; Sánchez-Payá J; Navarrete-Rueda F; Manzanares-Robles J; Gasparini-Berenguer R; Romero-Lorenzo R; Cortés-Gómez MA; Monge-Argilés JA
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577877
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
    Badiola N; de Oliveira RM; Herrera F; Guardia-Laguarta C; Gonçalves SA; Pera M; Suárez-Calvet M; Clarimon J; Outeiro TF; Lleó A
    PLoS One; 2011; 6(10):e26609. PubMed ID: 22039514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    Calderón-Garcidueñas L; Avila-Ramírez J; Calderón-Garcidueñas A; González-Heredia T; Acuña-Ayala H; Chao CK; Thompson C; Ruiz-Ramos R; Cortés-González V; Martínez-Martínez L; García-Pérez MA; Reis J; Mukherjee PS; Torres-Jardón R; Lachmann I
    J Alzheimers Dis; 2016 Sep; 54(2):597-613. PubMed ID: 27567860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss.
    Snow AD; Cummings JA; Tanzi RE; Lake T
    Sci Rep; 2021 Feb; 11(1):3001. PubMed ID: 33589649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.